We commenced GH treatment at 48 hours after stroke and found that mTOR protein expression and GluR1 were increased after 28 days of r-hGH treatment, when cell death is most likely complete [52], indicating that increased mTOR and GluR1 expression during the recovery phase of stroke may be beneficial by increasing neuroplasticity and reducing tissue loss. This evidence concerns the gene GH1 and stroke disorder.